XML 16 R7.htm IDEA: XBRL DOCUMENT v3.22.4
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Registered Shares
Additional Paid-in Capital
Treasury Shares
Retained Earnings
Accumulated Other Comprehensive Loss
Beginning of the period at Mar. 31, 2021 $ 2,261,789 $ 30,148 $ 129,519 $ (279,541) $ 2,490,578 $ (108,915)
Beginning of the period (in shares) at Mar. 31, 2021   173,106        
Beginning of the period (in shares) at Mar. 31, 2021       4,799    
Increase (Decrease) in Shareholders' Equity            
Total comprehensive income 526,027       536,308 (10,281)
Purchases of registered shares (290,625)     $ (290,625)    
Purchases of registered shares (in shares)       3,035    
Sales of shares upon exercise of stock options and purchase rights 16,644   8,397 $ 8,247    
Sales of shares upon exercise of stock options and purchase rights (in shares)       (226)    
Issuance of shares upon vesting of restricted stock units (58,528)   (93,967) $ 35,439    
Issuance of shares upon vesting of restricted stock units (in shares)       (969)    
Share-based compensation 72,045   72,045      
Cash dividends (159,410)       (159,410)  
End of the period at Dec. 31, 2021 2,367,942 $ 30,148 115,994 $ (526,480) 2,867,476 (119,196)
End of the period (in shares) at Dec. 31, 2021   173,106        
End of the period (in shares) at Dec. 31, 2021       6,639    
Beginning of the period at Sep. 30, 2021 2,262,683 $ 30,148 99,434 $ (413,345) 2,657,465 (111,019)
Beginning of the period (in shares) at Sep. 30, 2021   173,106        
Beginning of the period (in shares) at Sep. 30, 2021       5,331    
Increase (Decrease) in Shareholders' Equity            
Total comprehensive income 201,834       210,011 (8,177)
Purchases of registered shares (116,245)     $ (116,245)    
Purchases of registered shares (in shares)       1,379    
Sales of shares upon exercise of stock options and purchase rights 8   8      
Issuance of shares upon vesting of restricted stock units (3,777)   (6,887) $ 3,110    
Issuance of shares upon vesting of restricted stock units (in shares)       (71)    
Share-based compensation 23,439   23,439      
End of the period at Dec. 31, 2021 2,367,942 $ 30,148 115,994 $ (526,480) 2,867,476 (119,196)
End of the period (in shares) at Dec. 31, 2021   173,106        
End of the period (in shares) at Dec. 31, 2021       6,639    
Beginning of the period at Mar. 31, 2022 $ 2,398,738 $ 30,148 129,925 $ (632,893) 2,975,681 (104,123)
Beginning of the period (in shares) at Mar. 31, 2022   173,106        
Beginning of the period (in shares) at Mar. 31, 2022 7,855     7,855    
Increase (Decrease) in Shareholders' Equity            
Total comprehensive income $ 310,235       323,080 (12,845)
Purchases of registered shares (327,731)     $ (327,731)    
Purchases of registered shares (in shares)       5,967    
Sales of shares upon exercise of stock options and purchase rights 16,064   (930) $ 16,994    
Sales of shares upon exercise of stock options and purchase rights (in shares)       (423)    
Issuance of shares upon vesting of restricted stock units (28,734)   (65,758) $ 37,024    
Issuance of shares upon vesting of restricted stock units (in shares)       (929)    
Share-based compensation 52,775   52,775      
Cash dividends (162,681)       (162,681)  
End of the period at Dec. 31, 2022 $ 2,258,666 $ 30,148 116,012 $ (906,606) 3,136,080 (116,968)
End of the period (in shares) at Dec. 31, 2022   173,106        
End of the period (in shares) at Dec. 31, 2022 12,470     12,470    
Beginning of the period at Sep. 30, 2022 $ 2,168,561 $ 30,148 106,130 $ (824,650) 2,995,927 (138,994)
Beginning of the period (in shares) at Sep. 30, 2022   173,106        
Beginning of the period (in shares) at Sep. 30, 2022       10,943    
Increase (Decrease) in Shareholders' Equity            
Total comprehensive income 162,179       140,153 22,026
Purchases of registered shares (90,170)     $ (90,170)    
Purchases of registered shares (in shares)       1,746    
Sales of shares upon exercise of stock options and purchase rights 3,214   (2,582) $ 5,796    
Sales of shares upon exercise of stock options and purchase rights (in shares)       (155)    
Issuance of shares upon vesting of restricted stock units (1,992)   (4,410) $ 2,418    
Issuance of shares upon vesting of restricted stock units (in shares)       (64)    
Share-based compensation 16,874   16,874      
End of the period at Dec. 31, 2022 $ 2,258,666 $ 30,148 $ 116,012 $ (906,606) $ 3,136,080 $ (116,968)
End of the period (in shares) at Dec. 31, 2022   173,106        
End of the period (in shares) at Dec. 31, 2022 12,470     12,470